| Project/Area Number |
11557138
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (B)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 展開研究 |
|---|
| Research Field |
Functional basic dentistry
|
|---|
| Research Institution | NAGASAKI UNIVERSITY |
|---|
Principal Investigator |
KATO Yuzo Nagasaki University、Professor, 歯学部, 教授 (20014128)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
KOBAYASHI Yasuhiro Nagasaki University、Research Associate, 歯学部, 助手 (20264252)
SHIBATA Mitsue Nagasaki University、Research Associate, 歯学部, 助手 (20274665)
SAKAI Hideaki Nagasaki University、Associate Professor, 歯学部, 助教授 (40225769)
AWAYA Akira Institute of Biological Science, Mitsui Pharmaceticals, Chief Researcher, 製品計画部, 主席部員
SAKAI Eiko Nagasaki University、Research Assistant, 歯学部, 教務職員 (10176612)
|
|---|
| Project Period (FY) |
1999 – 2001
|
| Project Status |
Completed (Fiscal Year 2001)
|
| Budget Amount *help |
¥13,200,000 (Direct Cost: ¥13,200,000)
Fiscal Year 2001: ¥3,000,000 (Direct Cost: ¥3,000,000)
Fiscal Year 2000: ¥4,400,000 (Direct Cost: ¥4,400,000)
Fiscal Year 1999: ¥5,800,000 (Direct Cost: ¥5,800,000)
|
|---|
| Keywords | _D-PDMP / Glycolipid / Metalloprotease / Osteoclast / Osteoprotegerin (OPG) / Processing Enzyme / RANKL / Shedding / ODF(RANKL) / 破骨細胞 / ODF / プロセッシング酵素 / プロセッシング / OPG / メタロプロテアーゼ / ADAM |
|---|
| Research Abstract |
RANKL (receptor activator of NF-KB ligand), an essential factor of osteoclastogenesis, exists as a membrane-bound and soluble form. Our aim was to identify its processing enzyme.
First, to establish soluble RANKL expression system, ST2 cells, preosteoclast like cells, were treated by vitamine D3 (Vit D3) and dexamethasone (Dex). In general, RANKL is not produced in ST2 cells. But when ST2 cells were treated with Vit D3 and Dex, soluble form (MW ; about 30 kDa) was secreted into culture medium. Identification of soluble form was carried out by LRP (ligand-receptor precipitation) method. LRP is a new Western blot analysis that can specifically concentrate the target protein by using specific binding between RANKL and OPG (osteoprotegerin).
Next, N-terminal ammo acid sequences of soluble RANKL were decided. The cleavage of membrane-bound to soluble form occurred between Arg (138) and Phe (139), and its cleavage was inhibited by KB8301, a metalloproteinase inhibitor. Currently, it is said that the candidate of processing enzyme is an ADAM family protein. Among them, mRNA expression of TACE (ADAM 17) and Kuzbanian (ADAM 10) were confirmed by RT-PCR.
To examine the role of glycolipids in osteoclast formation, glycosylceramide synthase inhibitor (D-PDMP) was added to culture medium. Although the differentiation of preosteoclast to osteoclast was completely blocked by addition of D-PDMP, exogenous lactosylceramid (LacCer) significantly recovered the osteoclast formation and the phosphorylation of NF-kB and ERK inhibited by ^D PDMP. These results suggest that LacCer is important for the differentiation of osteoclast.
|
